Malika Ammam received her MS degree from the University of Pierre et Marie CURIE in July 2002 and her PhD from the University of Paris Sud XI, France in September 2005. From 2006 to 2007, she worked as a research fellow at the University of Kansas in collaboration with Pinnacle Technology Inc. (USA). From 2007 to 2010, she was a research associate at KU Leuven, Belgium. From 2010 to 2012, she worked at the University of Ontario Institute of Technology in collaboration with Alcohol Countermeasure Systems Corporation, Canada. She held a prestigious Rosalind Franklin fellowship and resigned in 2015. Now, she is a freelancer.
A collaborative research study led by researchers at Thomas Jefferson University revealed that energy processes used by breast cancer cells could differ from those of healthy cells, possibly leading to the ... Read more
Researchers have developed a novel method to study the mechanism by which estrogen/progesterone hormone receptors interact with DNA to regulate breast tumor growth. The paper entitled “Progesterone receptor modulates ERα action in ... Read more
A newly published paper in Cell Reports journal, entitled “Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity,” reported new insights into the reasons ... Read more
In a recent study published in Nature journal entitled “Progesterone receptor modulates ERα action in breast cancer“, scientists found that the female hormone progesterone may help in breast cancer treatment. ... Read more